Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, remains a significant health concern worldwide. This article provides an updated approach to the diagnosis and treatment of enteric fever, incorporating recent advancements in medical science.
Early diagnosis of enteric fever is crucial for effective management. The gold standard for diagnosis remains blood culture, which has a sensitivity of 40-60%. However, this method is limited by the need for sophisticated laboratories and slow turnaround times. Recent advancements include the introduction of rapid diagnostic tests (RDTs) such as the Typhidot and Tubex TF, which are based on detecting IgM antibodies against the bacteria. These RDTs have shown promising results in endemic regions, with higher sensitivity and specificity compared to traditional methods.
Treatment of enteric fever has been complicated by the emergence of multidrug-resistant strains. The World Health Organization currently recommends ceftriaxone or cefixime for uncomplicated cases, and ciprofloxacin for complicated cases. However, due to increasing resistance, azithromycin has emerged as a viable alternative. Adjunctive therapies, such as probiotics and zinc supplementation, are also being explored to reduce the duration and severity of illness.
Prevention strategies are key in controlling the spread of enteric fever. Vaccination remains the most effective measure, with the Vi polysaccharide and Ty21a vaccines showing good efficacy. In addition, improving water quality, sanitation, and hygiene practices are crucial in endemic regions to reduce transmission.
Enteric fever continues to present significant challenges in diagnosis and treatment. Incorporating rapid diagnostic tests into clinical practice and exploring alternative treatment options, such as azithromycin, may improve patient outcomes. A multifaceted approach encompassing prevention strategies, including vaccination and improved sanitation, is essential to control the spread of this disease.
1.
Global warming could be driving up women's cancer risk, find researchers
2.
Blood tests can predict the risk of relapse after a bone marrow transplant in patients with acute myeloid leukemia.
3.
Survey shows cancer anxiety has impact well beyond the individual diagnosed
4.
MRI can save rectal cancer patients from surgery, study suggests
5.
Glioma Outcomes Shaped by Subtype More Than Tx Sequence
1.
Rehabilitation After Organ-Conserving Cancer Surgery
2.
Practical Breakthroughs in Oncology Across Clinical Settings
3.
Gynecologic Oncology: Advances, Education, and Clinical Excellence
4.
Breaking Down the Different Types of Lymphoma: What You Need to Know
5.
RNA-Targeting Chimeras in Cancer: Mechanisms, Clinical Advances, and Future Directions
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Cancer Care: From Awareness to Recovery
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
5.
A Conclusive Discussion on CROWN Trial and the Dawn of a New Era in Frontline Management of ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation